# Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Psoriasis

> **NCT00658827** · — · COMPLETED · sponsor: **Janssen Biotech, Inc.** · enrollment: 370 (actual)

## Conditions studied

- Inflammatory Bowel Disease

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT00658827
- **Lead sponsor:** Janssen Biotech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01-01
- **Primary completion:** 2016-09-30
- **Final completion:** 2016-09-30
- **Target enrollment:** 370 (ACTUAL)
- **Last updated:** 2025-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00658827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00658827, "Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Psoriasis". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00658827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*